Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 498Rectal Neoplasms 268Colonic Neoplasms 219Pancreatic Neoplasms 190Stomach Neoplasms 183Esophageal Neoplasms 135Neoplasm Metastasis 98Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 62Carcinoma, Hepatocellular 56Neoplasms 44Cholangiocarcinoma 33Biliary Tract Neoplasms 27Adenocarcinoma 27Anus Neoplasms 26Gastrointestinal Neoplasms 25Gallbladder Neoplasms 22Liver Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Bile Duct Neoplasms 19Parkinson Disease 4, Autosomal Dominant Lewy Body 16Ovarian Neoplasms 11Digestive System Neoplasms 10Colorectal Cancer Metastatic 10Carcinoma, Squamous Cell 10Peritoneal Neoplasms 9Breast Neoplasms 9Anal Canal Carcinoma 9Lung Neoplasms 8Head and Neck Neoplasms 8

Interventions

Oxaliplatin 1Levoleucovorin 1Leucovorin 1Folfox protocol 1Fluorouracil 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumour × Fluorouracil × Gastrointestinal × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡